These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8156882)

  • 1. [Neutralizing antibodies against salmon calcitonin. The cause of a treatment failure in Paget's disease].
    Grauer A; Frank-Raue K; Schroth J; Raue F; Ziegler R
    Dtsch Med Wochenschr; 1994 Apr; 119(14):507-10. PubMed ID: 8156882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
    Haddad JG; Caldwell JG
    J Clin Invest; 1972 Dec; 51(12):3133-41. PubMed ID: 4674398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
    Kuhlencordt F; Ringe JD; Kruse HP
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1620-3. PubMed ID: 7308002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcine calcitonin in the treatment of Paget's disease of bone: experience with 32 patients.
    Plehwe WE; Hudson J; Clifton-Bligh P; Posen S
    Med J Aust; 1977 Apr; 1(16):577-81. PubMed ID: 559908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
    Deplante JP; Daumont A; Bouvier M; Lejeune E
    Nouv Presse Med; 1978 Nov; 7(41):3753-6. PubMed ID: 733525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease.
    Levy F; Muff R; Dotti-Sigrist S; Dambacher MA; Fischer JA
    J Clin Endocrinol Metab; 1988 Sep; 67(3):541-5. PubMed ID: 3410939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Paget's disease with salmon thyrocalcitonin. Cooperative double-blind study].
    Bouvet JP
    Nouv Presse Med; 1976 Apr; 6(17):1447-50. PubMed ID: 67592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K; Schmidt UJ; Abendroth K; Ansorg H; Graner H; Lindenhayn K; Schramm G; Kalbe I
    Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of the painful Paget's disease of the pelvis with salmon calcitonin in ambulant care. Studies in 2 cases during 26 and 19 months respectively].
    Staehelin A
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1704-5. PubMed ID: 1215961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmon and porcine calcitonin treatment of Paget's disease of bone.
    Avramides A
    Clin Orthop Relat Res; 1977; (127):78-85. PubMed ID: 303164
    [No Abstract]   [Full Text] [Related]  

  • 13. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
    Avramides A; Flores A; DeRose J; Wallach S
    J Clin Endocrinol Metab; 1976 Mar; 42(3):459-63. PubMed ID: 1254686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin.
    Grauer A; Raue F; Schneider HG; Frank-Raue K; Ziegler R
    J Bone Miner Res; 1990 Apr; 5(4):387-91. PubMed ID: 2343778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance.
    Singer FR; Fredericks RS; Minkin C
    Arthritis Rheum; 1980 Oct; 23(10):1148-54. PubMed ID: 7000081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intermittent treatment of Paget's disease of bone with calcitonin: histological study].
    Eisinger J; Laponche AM
    Rev Rhum Mal Osteoartic; 1976; 43(7-9):511-6. PubMed ID: 981933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic human calcitonin in refractory Paget's disease of bone.
    Altman RD; Collins-Yudiskas B
    Arch Intern Med; 1987 Jul; 147(7):1305-8. PubMed ID: 3111398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG; Husdan H; Harrison J; Meema HE; McNeill KG; Murray TM; Ogilvie R; Rapoport A
    Can Med Assoc J; 1977 Apr; 116(8):851-5. PubMed ID: 856428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE
    Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC; Meunier P; Terrier M; David L; Vignon G
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.